Dr. Soliman Abdel Kader Fakeeh Hospital Co. announces its Interim Financial results for the Period Ending on 2024-03-31 ( Three Months )
| Element List | Current Quarter | Similar quarter for previous year | %Change | Previous Quarter | % Change |
|---|---|---|---|---|---|
| Sales/Revenue | 680.33 | 529.41 | 28.507 | 662.32 | 2.719 |
| Gross Profit (Loss) | 188.58 | 144.4 | 30.595 | 163.36 | 15.438 |
| Operational Profit (Loss) | 107 | 84.19 | 27.093 | 95.91 | 11.562 |
| Net profit (Loss) | 60.7 | 60.52 | 0.297 | 63.11 | -3.818 |
| Total Comprehensive Income | 60.7 | 60.52 | 0.297 | 55.9 | 8.586 |
| All figures are in (Millions) Saudi Arabia, Riyals | |||||
| Element List | Current Period | Similar period for previous year | %Change |
|---|---|---|---|
| Total Shareholders Equity (after Deducting Minority Equity) | 1,092.98 | 1,969.68 | -44.509 |
| Profit (Loss) per Share | 0.36 | 0.36 | |
| All figures are in (Millions) Saudi Arabia, Riyals | |||
| Element List | Amount | Percentage of the capital (%) | |
|---|---|---|---|
| Profit (Losses) Resulting From The Change In Investment Propertie’s Fair Value | - | - | |
| All figures are in (Millions) Saudi Arabia, Riyals | |||
| Element List | Explanation |
|---|---|
| The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the same quarter of the last year is | Revenue in the current quarter increased by 28.5% to reach 680.3M from 529.4M in Q1 2023, driven by growing patient numbers in Jeddah and Riyadh, further supported by the Group's operate and manage (O&M) contract in NEOM. |
| The reason of the increase (decrease) in the net profit during the current quarter compared to the same quarter of the last year is | Net profit in the current quarter increased by 0.3% to reach 60.7M from 60.5M in Q1 2023, with revenue growth being offset partly by higher finance charges, higher depreciation on additional investments and higher provisions for zakat. Net Profit in Q1 2023 also included a one-off finance income of 11.9M from a long-term receivable balance which was settled in September 2023.
EBITDA in the current quarter increased by 10.7% to reach 144.5M from 130.6M in Q1 2023, reflecting strong revenue growth and optimized cost structure. EBITDA in Q1 2023 also included a one-off finance income of 11.9M from a long-term receivable balance which was settled in September 2023. |
| The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the previous one is | Revenue reached 680.3M, higher by 2.7% from 662.3M of the preceding quarter due to stronger hospital census and increased activity within the O&M contract, despite the impact of seasonality. |
| The reason of the increase (decrease) in the net profit (loss) during the current quarter compared to the previous one is | Net profit reached 60.7M, lower 3.8% from 63.1M in the preceding quarter as a result of increased finance charges and zakat provisions.
EBITDA reached 144.5M, higher by 6.4% from 135.7M of the preceding quarter as a result of top-line growth reflecting in better operating profit. |
| Statement of the type of external auditor's report | Unmodified conclusion |
| Comment mentioned in the external auditor’s report, mentioned in any of the following paragraphs (other matter, conservation, notice, disclaimer of opinion, or adverse opinion) | NA |
| Reclassification of Comparison Items | Yes |
| Additional Information | NA |
| Attached Documents |  |
Comments